Indeed, high-dose EPO, but not low-dose, improved sepsis survival in all models, except for LPS, regardless of the preconditioning kidney injury (Figure 3A–D) without an effect on SBP (Figure 3E–H). This evidence concerns the gene EPO and Sepsis.